Arrowhead Pharmaceuticals Inc (ARWR)
22.52
-1.15
(-4.86%)
USD |
NASDAQ |
Apr 17, 16:00
22.47
-0.05
(-0.22%)
Pre-Market: 08:20
Arrowhead Pharmaceuticals Accounts Payable (Quarterly): 4.46M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.46M |
September 30, 2023 | 35.87M |
June 30, 2023 | 7.874M |
March 31, 2023 | 9.556M |
December 31, 2022 | 0.796M |
September 30, 2022 | 2.868M |
June 30, 2022 | 5.894M |
March 31, 2022 | 10.60M |
December 31, 2021 | 4.068M |
September 30, 2021 | 9.457M |
June 30, 2021 | 10.04M |
March 31, 2021 | 5.299M |
December 31, 2020 | 4.827M |
September 30, 2020 | 6.829M |
June 30, 2020 | 4.074M |
March 31, 2020 | 13.42M |
December 31, 2019 | 12.20M |
September 30, 2019 | 7.650M |
June 30, 2019 | 4.630M |
March 31, 2019 | 4.062M |
December 31, 2018 | 3.937M |
September 30, 2018 | 2.806M |
June 30, 2018 | 2.166M |
March 31, 2018 | 1.810M |
December 31, 2017 | 5.707M |
Date | Value |
---|---|
September 30, 2017 | 4.076M |
June 30, 2017 | 3.233M |
March 31, 2017 | 2.598M |
December 31, 2016 | 3.698M |
September 30, 2016 | 12.23M |
June 30, 2016 | 5.945M |
March 31, 2016 | 7.542M |
December 31, 2015 | 5.289M |
September 30, 2015 | 5.032M |
June 30, 2015 | 4.862M |
March 31, 2015 | 4.936M |
December 31, 2014 | 5.995M |
September 30, 2014 | 2.580M |
June 30, 2014 | 2.158M |
March 31, 2014 | 2.512M |
December 31, 2013 | 0.5893M |
September 30, 2013 | 1.200M |
June 30, 2013 | 1.062M |
March 31, 2013 | 0.8717M |
December 31, 2012 | 0.8095M |
September 30, 2012 | 0.878M |
June 30, 2012 | 0.9944M |
March 31, 2012 | 0.8011M |
December 31, 2011 | 0.7141M |
September 30, 2011 | 0.5768M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.796M
Minimum
Dec 2022
35.87M
Maximum
Sep 2023
8.442M
Average
6.829M
Median
Sep 2020
Accounts Payable (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 28.04M |
Viking Therapeutics Inc | 7.512M |
Akero Therapeutics Inc | 7.038M |
89bio Inc | 8.585M |
Sagimet Biosciences Inc | 0.186M |